Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen

Journal of Ocular Pharmacology and Therapeutics

Volumn 16, Issue 4, 2000, Pages 353-361

  Van Haeringen, N J ^a   Van Sorge, A A ^b   Carballosa Core Bodelier, V M W ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FLURBIPROFEN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN TISSUE; IRIS; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION;

EID: 0033836777     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2000.16.353     Document Type: Article

References (43)

1. The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle
2. 2 in prostaglandin biosynthesis
3. Cellular triglyceride as a source of fatty acid for lecithin synthesis during phagocytosis
4. Purification of cyclooxygenase that forms prosta-glandins: Demonstration of two forms of iron in the holoenzyme
5. Multiple cyclooxygenases: Cloning of a mitogen inducible form
6. Prostaglandin synthesis and accumulation by porcine ciliary epithelium
7. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
8. Expression of mitogen responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
9. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and gluco-corticoids
10. Cytokine-mediated induction of cyclooxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide
11. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages
12. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene
13. 2 synthesis
14. Platelet-activating factor induces cyclo-oxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway
15. Induction of rabbit cyclooxygenase 2 in the anterior uvea following glaucoma filtration surgery
16. 2-like activity into aqueous humor after paracentesis and its prevention by aspirin
17. Prostaglandins as mediators of the responses of the eye to trauma
18. Prostaglandin-like activity in the aqueous humor following alkali burns
19. Inhibition of the ocular effects of sodium arachidonate by anti-inflammatory compounds
20. The response of the rabbit eye to laser irradiation of the iris
21. The synthesis of cyclooxygenase products in ocular tissues of various species
22. Release of a prostaglandin in ocular inflammation
23. Release of prostaglandin-like substances by Shigella endotoxin and its inhibition by nonsteroidal anti-inflammatory compounds
24. Specificity of flurbiprofen and enantiomers for inhibition of prostaglandin syntheses in bovine iris/ciliary body
25. Prostaglandin thromboxane synthesis by microsomes of inflamed rabbit ciliary body-iris
26. Differential inhibition of human prostaglandin endoperoxidase synthase-1 and -2 by nonsteroidal anti-inflammatory drugs
27. Role of cyclooxygenase isozyme in inflammation and pain in rabbit eye
28. Cytochrome P450-mediated prostaglandin ω/ω-1 hydroxylase activities in porcine ciliary epithelial cells
29. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood
30. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal anti-inflammatory drugs
31. The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen
32. 2 of rabbit polymorphonucleate leukocytes
33. 2: Selection inhibition of group II enzymes by indomethacin but not other NSAIDs
34. A comparison of the effects of non-steroidal compounds on the disruption of the blood-aqueous barrier
35. 4, and (S)-flurbiprofen following extraction of impacted third molars
36. d-Ibuprofen in ocular inflammation induced by paracentesis of the rabbit eye
37. Stereoselective high performance liquid chromatographic determination of flurbiprofen in plasma
38. Variability of inversion of R(-)-flurbiprofen in different species
39. Flurbiprofen, S(+), eye drops: Formulation, enantiomeric assay, shelf-life and pharmacology
40. Antinociceptive actions of R(-)-flurbiprofen-a non-cyclooxygenase inhibiting 2-arylpropionic acid-in rats
41. Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application
42. Cyclooxygenase-2 inhibitors: A new approach to the therapy of ocular inflammation
43. Local tissue tolerability of meloxicam, a new NSAID: Indications for parenteral, dermal and mucosal administration